ATM and Glucose intolerance: Circulating levels of MCP-1 are increased in animal models of diet-induced obesity [67, 68] where it appears to play a role in HFD-induced insulin resistance, glucose intolerance [52, 69] and ATM infiltration [52, 69, 70].